R Takayanagi
Overview
Explore the profile of R Takayanagi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
175
Citations
1668
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Negoro T, Shimizu S, Narushima M, Banham A, Wakabayashi H, Takayanagi R, et al.
Clin Exp Allergy
. 2014 Jul;
44(9):1154-69.
PMID: 25048599
Background: Regulatory T cells (T(regs)) are activated during anergy in response to T cell receptor (TCR) activation and functional immune suppression. Anergy of paediatric T(regs) is partially dependent on intracellular...
2.
Kimura S, Inoguchi T, Yokomizo H, Maeda Y, Sonoda N, Takayanagi R
Diabetes Obes Metab
. 2012 Jan;
14(7):666-9.
PMID: 22268518
The effect of pitavastatin and pravastatin treatment on renal function was compared in type 2 diabetic patients with nephropathy in a randomized, controlled, open-label, parallel and multi-centre study. Type 2...
3.
Li H, Kilpelainen T, Liu C, Zhu J, Liu Y, Hu C, et al.
Diabetologia
. 2011 Nov;
55(4):981-95.
PMID: 22109280
Aims/hypothesis: FTO harbours the strongest known obesity-susceptibility locus in Europeans. While there is growing evidence for a role for FTO in obesity risk in Asians, its association with type 2...
4.
Ikeda N, Inoguchi T, Sonoda N, Fujii M, Takei R, Hirata E, et al.
Diabetologia
. 2011 May;
54(8):2183-91.
PMID: 21614569
Aims/hypothesis: We have previously shown a negative correlation between serum bilirubin levels and prevalence of type 2 diabetes, suggesting that bilirubin inhibits development of this disease. To confirm this hypothesis,...
5.
Iguchi H, Morita R, Yasuda D, Takayanagi R, Ikeda Y, Takada Y, et al.
Oncol Rep
. 2011 May;
1(6):1223-7.
PMID: 21607521
Alterations of the p53 and Ki-ras genes were examined in 12 human pancreatic cancer-derived cell lines with different metastatic potential. Point mutations of the Ki-ras gene at codon 12 were...
6.
Nishi Y, Haji M, Takayanagi R, Iguchi H, Shimazoe T, Hirata J, et al.
Int J Oncol
. 2011 May;
5(1):33-9.
PMID: 21559554
Human pancreatic ductal cell carcinoma cell line, which can secrete parathyroid hormone-related peptide (PTHrP), designated as KP 4, and its daughter cell lines with different PTHrP-secreting activities, termed KP 4-1...
7.
Takeuchi F, Yamamoto K, Katsuya T, Nabika T, Sugiyama T, Fujioka A, et al.
Diabetologia
. 2011 Mar;
54(6):1350-9.
PMID: 21369819
Aims/hypothesis: In populations of East Asian descent, we performed a replication study of loci previously identified in populations of European descent as being associated with obesity measures such as BMI...
8.
Iwasa T, Nakamura K, Ogino H, Itaba S, Akiho H, Okamoto R, et al.
Endoscopy
. 2010 Nov;
43(1):70-2.
PMID: 21108178
Tocilizumab is a monoclonal antibody against human interleukin-6 receptor which blocks the binding of interleukin-6 to its receptor. Tocilizumab is effective for the treatment of inflammatory disorders including rheumatoid arthritis....
9.
Hamada Y, Naitoh H, Niibe Y, Kotani A, Takayanagi R, Tsunoda S, et al.
Eur J Gynaecol Oncol
. 2010 Nov;
31(5):517-21.
PMID: 21061792
Purpose: Established therapeutic guidelines for cervical carcinoma recommend concurrent chemo- and radiotherapy as standard treatment for locally advanced cervical carcinoma. Nedaplatin (CDGP) is a platinum agent developed in Japan that...
10.
Higuchi N, Akahoshi K, Honda K, Matsui N, Kubokawa M, Motomura Y, et al.
Endoscopy
. 2010 Mar;
42 Suppl 2:E107-8.
PMID: 20306394
No abstract available.